Lin Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Abstract: The present invention falls within the technical field of medicine, and in particular relates to PDE9 inhibitor compounds as shown in formula (I) or pharmaceutically acceptable salts or stereoisomers thereof, and also relates to pharmaceutical preparations and pharmaceutical compositions of the compounds and the uses thereof. X1, X2, X3, X4, R1, R2, ring A, L and m are as defined in the description. The compounds can be used to prepare drugs for treating or preventing related diseases mediated by PDE9.
Abstract: A method for manufacturing an integral shoe embryo is provided. In the method, a reinforcement piece is woven by a flat knitting machine during a weave process, and the reinforcement piece is made unperceivable through a subsequent side overturning step when viewing from an exterior of a shoe. Thus, with the reinforcement piece, structural strength of the shoe embryo is reinforced while better comfort is provided to the foot by a shoe manufactured from the shoe embryo.
April 26, 2017
Date of Patent:
January 5, 2021
WHOLEKNIT INTERNATIONAL CO., LTD.
Ming-Sheng Kuo, Yu-Lin Li, Chien-Hui Yang
Abstract: The present invention relates to the technical field of pharmaceuticals, and particularly to a peptidylarginine deiminase (PAD4) inhibitor compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer and tautomer thereof, and pharmaceutical composition, pharmaceutical formulation and use thereof. X, Y, R1, R2, R3, R4, R5, R7, R8, R9, ring B and m are defined in the specification. The compound disclosed herein has an inhibitory effect on peptidylarginine deiminase (PAD4), and can be used to treat a variety of diseases, such as rheumatoid arthritis, vasculitis, systemic lupus erythematosus, ulcerative colitis, multiple sclerosis, cystic fibrosis, cancer, cutaneous lupus erythematosus, asthma and psoriasis.
Abstract: An accelerated compression method and apparatus are provided. The accelerated compression apparatus includes a look-ahead buffer, a string matching processing pipeline and a control circuit. The string to be compressed extracted from the data register is stored to the look-ahead buffer. A string to be compressed includes Q characters, and a repeat flag is stored in the look-ahead buffer for each character in the string to be compressed. P instances are issued in parallel in each issue cycle. When all the characters included in P substrings corresponding to the P instances are identical to each other, the control circuit sets the repeat flags of the start characters corresponding to the last (P?1) instances among the P instances to a set state.
Abstract: Provided is a full-time duplex system. The system includes: a receiving antenna (107), a transmitting antenna (108), a transmitting channel (109), an LNA (106), a mode determination unit (101), a power detection amplitude phase adjustment unit (102), an RSSI detection amplitude phase adjustment unit (103) and an amplitude phase unit (104); the power detection amplitude phase adjustment unit (102) is electrically connected between the receiving antenna (107) and the low noise amplifier (106) and also between the transmitting antenna (108) and the transmitting channel (109); the mode determination unit (101) notifies, according to a power range which a signal transmitting power of the full-time duplex system belongs to, one of the power detection amplitude phase adjustment unit (102) or the RSSI detection amplitude phase adjustment unit (103) of controlling the amplitude phase unit (104) to adjust an amplitude and a phase of a transmitting cancellation signal.
Abstract: A compound for treatment or prevention of obesity or diseases related to obesity, and an application thereof. Specifically, provided are a compound as represented by formula I, or a pharmaceutically-acceptable salt thereof, and a pharmaceutical composition containing the compound. The compound has multiple functions and can be used for treatment or prevention of obesity or diseases related to obesity.
September 21, 2018
December 10, 2020
Yunfu ZHOU, Lin LI, Xiaojiang HAO, Duozhi CHEN
Abstract: A touch panel with electromagnetic induction function comprising a light-emitting diode backlight layer, an electromagnetic antenna, a display panel layer, a touch panel layer and a protective layer. The light emitting diode backlight layer has a plurality of light emitting diode units. The electromagnetic antenna is disposed on the backlight layer for emitting an alternating electromagnetic field and receiving a resonance signal. The display panel layer is disposed on the backlight layer. The touch panel layer is disposed on the display panel layer for capacitive touch. The protective layer is disposed on the touch panel layer to protect the touch panel layer. An electromagnetic pen for electromagnetic touch is configured to receive the alternating electromagnetic field and then emit the resonance signal.
Abstract: A method of tracking a face includes determining a current frame from video stream data in response to receiving a face tracking instruction; detecting a position of a face in the current frame, and obtaining a historical motion trajectory of the face in the current frame; predicting the position of the face in the current frame based on the historical motion trajectory to obtain a predicted position of the face; obtaining a correlation matrix of the historical motion trajectory and the face in the current frame based on the predicted position and the detected position; and updating the historical motion trajectory based on the correlation matrix, and tracking the face in a next frame based on the updated historical motion trajectory.
August 17, 2020
December 3, 2020
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
Chang Wei He, Cheng Jie Wang, Ji Lin Li, Jin Long Peng, Ya Biao Wang, Yan Dan Zhao, Zhen Ye Gan, Yong Jian Wu, Fei Yue Huang
Abstract: The present disclosure provides a protection group superposition switching method, a control apparatus, and an optical communication device. Multiple protection state machines are implemented by using a field programmable gate array (FPGA). Each protection state machine independently performs an automatic protection switching (APS) protocol operation for at least one protection group that is pre-associated with the protection state machine. At least one protection status table for recording a status of each protection group is updated according to a result of the APS protocol operation, and a cross-connection table for traffic cross-connection between communication units is updated according to the protection status table; the updated cross-connection table is configured into a cross-connection chip, so that the cross-connection chip performs traffic cross-connection according to the updated cross-connection table.
Abstract: A method to align a next generation sequencing read to a reference sequence includes: (a) receiving a sequencing read; (b) performing a first alignment of the sequencing read to a reference sequence so as to identify a target sequence within the reference sequence whereto the sequencing read maps; (c) selecting a first and a second anchor sequence; (d) attaching the first anchor sequence to the upstream region of the sequencing read and the second anchor sequence to the downstream region of the sequencing read so as to generate an extended sequencing read; (e) attaching the first anchor sequence to the upstream region of the target sequence and the second anchor sequence to the downstream region of the target sequence, so as to generate an extended target sequence; (f) performing a second alignment of the extended sequencing read to the extended target sequence, so that the second alignment is more correctly mapped to the target sequence than the first alignment; (g) identifying a position where one or more b
Abstract: A method, an apparatus, a device, and a storage medium for managing an access request are provided. The method includes acquiring a group of access requests for performing data access to a storage device in a computing system, the group of access requests indicating access operations for a group of addresses in the storage device respectively; arranging an order of the group of addresses based on address ranges of the addresses of the group of addresses in the storage device; generating a merged request based on at least one part of the access requests with consecutive addresses among the group of access requests with the arranged addresses; and executing a data access operation on the storage device based on the merged request, the method being implemented in a driver of the storage device, and the driver being implemented in a user state of the computing system.
Abstract: Embodiments of the present disclosure provide a method, apparatus, device, and storage medium for processing an access request, and relate to the field of cloud computing. The method includes: acquiring a plurality of to-be-distributed access requests for a storage device, the access requests at least including a group of read requests and a group of write requests; distributing read requests of the group of read requests to a drive device of the storage device without distributing a write request of the group of write requests, until a number of distributed read requests reaches a total number of read requests of the group of read requests or a first threshold number, the drive device being configured to execute the distributed requests on the storage device; and distributing at least one write request of the group of write requests to the drive device.
Abstract: A shoe embryo tailored from a tubular fabric is provided. The shoe embryo includes a sole portion, a toe cap portion located at one end of the sole portion, a heel portion located at the other end of the sole portion, and an ankle portion located above the sole portion and near the heel portion. The ankle portion includes an ankle opening overlock line formed by trimming the tubular fabric and overlocking. The heel portion includes a heel overlock line formed by trimming the tubular fabric and overlocking, and a sole overlock line formed by folding below the heel overlock line and overlocking. The toe cap portion includes a toe cap overlock line formed by trimming the tubular fabric and overlocking.
November 22, 2016
Date of Patent:
November 24, 2020
Wholeknit International Co., Ltd.
Ming-Sheng Kuo, Yu-Lin Li, Chien-Hui Yang
Abstract: The present invention belongs to the technical field of medicine, and particularly relates to a compound represented by Formula I, a pharmaceutically acceptable salt thereof, and a stereoisomer thereof, R4, R4?, R5, R5?, R6, R7, R1a, R2a, m, n, t1, and t2 are as defined in the description; the present invention further relates to a Crystalline Form of the compound represented by Formula I, and the present invention also relates to a pharmaceutical preparation, a pharmaceutical composition, a preparation method of these compounds and Crystalline Forms thereof, as well as a use thereof in manufacture of a medicament for treating a related disease mediated by abnormality of indoleamine 2,3-dioxygenase (IDO).